TRMK trades 3.4% below Wall Street's consensus target of $47.50.
Last 12 months price action with 12-month analyst target path
The base valuation assumes TRMK achieves its forward estimates and maintains a stable P/E multiple of 11.6x. This scenario reflects the blended consensus of 9 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of September 23, 2026, Trustmark Corporation (TRMK) has a Wall Street consensus price target of $47.50, based on estimates from 9 covering analysts. With the stock currently trading at $45.94, this represents a potential upside of +3.4%. The company has a market capitalization of $2.69B.
Analyst price targets range from a low of $47.00 to a high of $48.00, representing a 2% spread in expectations. The median target of $47.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 0 analysts rating the stock as a Buy or Strong Buy,7 rating it Hold, and 2 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, TRMK trades at a trailing P/E of 12.4x and forward P/E of 11.6x. The forward PEG ratio of 1.44 indicates reasonable valuation for growth. Analysts expect EPS to grow -0.7% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $54.49, with bear and bull scenarios of $34.33 and $71.79 respectively. Model confidence stands at 50/100, reflecting moderate uncertainty in projections.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 HOMBHome Bancshares, Inc. | $5.9B | $29.14 | $33.25 | +14.1% | Hold | 11.6x | 19 |
 SFNCSimmons First National Corporation | $3.3B | $22.50 | $26.17 | +16.3% | Buy | 11.0x | 9 |
 HOPEHope Bancorp, Inc. | $1.8B | $13.78 | $16.00 | +16.1% | Hold | 12.8x | 6 |
 IBCPIndependent Bank Corporation | $734M | $35.62 | $39.50 | +10.9% | Hold | 10.0x | 8 |
 RNSTRenasant Corporation | $3.6B | $39.76 | $48.00 | +20.7% | Buy | 10.5x | 16 |
 FFINFirst Financial Bankshares, Inc. | $4.6B | $32.31 | $35.33 | +9.3% | Hold | 15.8x | 16 |
 BOKFBOK Financial Corporation | $8.0B | $131.05 | $149.00 | +13.7% | Hold | 12.3x | 21 |
 UMBFUMB Financial Corporation | $10.2B | $134.21 | $168.50 | +25.5% | Buy | 10.1x | 18 |
 CVBFCVB Financial Corp. | $3.2B | $22.16 | $26.67 | +20.4% | Hold | 14.7x | 16 |
 BANRBanner Corporation | $2.3B | $68.88 | $75.00 | +8.9% | Hold | 11.6x | 13 |
Quick answers to the most common questions about buying TRMK stock.
The consensus price target for TRMK is $47.5, close to the current price of $45.94 (3.4% implied move). Based on 9 analyst estimates, the stock appears fairly valued near current levels.
TRMK has a consensus rating of "Hold" based on 9 Wall Street analysts. The rating breakdown is leaning bearish, with 2 Sell/Strong Sell ratings. The consensus 12-month price target of $47.5 implies 3.4% upside from current levels.
With a forward P/E of 11.5864x, TRMK trades at a relatively low valuation. The consensus target of $47.5 implies 3.4% appreciation, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $48 for TRMK, while the most conservative target is $47. The consensus of $47.5 represents the median expectation. Our quantitative valuation model projects a bull case target of $72 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
TRMK is moderately covered, with 9 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 0 have Buy ratings, 7 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month TRMK stock forecast based on 9 Wall Street analysts shows a consensus price target of $47.5, with estimates ranging from $47 (bear case) to $48 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $54, with bear/bull scenarios of $34/$72.
Our quantitative valuation model calculates TRMK's fair value at $54 (base case), with a bear case of $34 and bull case of $72. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 50/100.
TRMK trades at a forward P/E ratio of 11.6x based on next-twelve-months earnings estimates compared to a trailing P/E of 12.4x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
TRMK appears fairly valued according to analysts, with a "Hold" rating and minimal upside to the $47.5 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
TRMK analyst price targets range from $47 to $48, a 2% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $47.5 consensus represents the middle ground. Our model's $34-$72 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.